BioSpace News Archive

DM1157 was designed to overcome the serious issue of growing drug resistance among malaria medicines.

Healogics® Inc., the nation’s largest provider of advanced chronic wound care services, today announced the launch of Healogics® iSupply.

The Pennsylvania Patient Safety Authority (the Authority) issued the “Final Recommendations to Ensure Accurate Patient Weights” in licensed acute care facilities in the Commonwealth.

This first of its kind program provides hospital partners with solutions to better manage total cost of care and quality outcomes related to wound care products

llinois-based Gateway Foundation (gatewayfoundation.org) announces that Karen Wolownik Albert, Executive Director of Gateway Foundation Lake Villa, is the 2018 recipient of the prestigious Dr. C. Vincent Bakeman Memorial Award.

Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organization, the Almac Group, is delighted to invite participants from the Biopharma Industry to join its fourth consecutive North American and seventh global “lunch and learn” seminar this year, building on its unique global knowledge share series.

Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that the United States Court of Appeals for the Federal Circuit, by a 2-1 vote, has upheld the United States District Court for the District of Delaware’s decision to invalidate four AMPYRA patents.

Eli Lilly and Company (NYSE: LLY) announced that it will present new data for Taltz® (ixekizumab), Olumiant® (baricitinib) and mirikizumab at the 27th annual European Academy of Dermatology and Venereology (EADV) Congress taking place Sep. 12-16, 2018, in Paris, France.

Technavio has announced their latest drug pipeline analysis report on celiac therapeutics. The report includes a comprehensive research on the pipeline molecules under investigation by the pharmaceutical companies within the defined data collection period for the treatment of celiac.

As germs and bacteria become increasingly resistant to cleaning chemicals and antibiotics, Hunterdon Medical Center recently deployed Xenex LightStrike™ Germ-Zapping Robots™ that use pulsed xenon ultraviolet (UV) light to enhance traditional room cleaning procedures as a key part of the hospital’s infection prevention program.